Publications

Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

 108
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

Tags:

Previous Article

Opposing roles for AMPK in regulating distinct mitophagy pathways

Next Article

Gene replacement therapy for hereditary spastic paraplegia type 47

Related Posts

Rhesus macaques with an OPA1 mutation demonstrate features of autosomal dominant optic atrophy

Rhesus macaques with an OPA1 mutation demonstrate featu...

 32

Tubulin transforms Tau and α-synuclein condensates from pathological to physiological

Tubulin transforms Tau and α-synuclein condensates from...

 41

Genomic atlas of Bifidobacterium infantis and B. longum informs infant probiotic design

Genomic atlas of Bifidobacterium infantis and B. longum...

 53